- Integrin alpha M
Integrin alpha M (ITGAM) is one protein subunit that forms the
heterodimer icintegrin alpha-M beta-2 (αMβ2) molecule, also known as "macrophage-1 antigen" (Mac-1 ) or "complement receptor 3" (CR3).cite journal |author=Solovjov D, Pluskota E, Plow E |title=Distinct roles for the alpha and beta subunits in the functions of integrin alphaMbeta2 |journal=J Biol Chem |volume=280 |issue=2 |pages=1336–45 |year=2005 |pmid=15485828 |doi=10.1074/jbc.M406968200] ITGAM is also known as CR3A, andcluster of differentiation molecule 11B (CD11B). The second chain of αMβ2 is the common integrin β2 subunit known asCD18 , and integrin αMβ2 thus belongs to the β2 subfamily (or leukocyte) integrins. [cite journal |author=Larson R, Springer T |title=Structure and function of leukocyte integrins |journal=Immunol Rev |volume=114 |issue= |pages=181–217 |year= |pmid=2196220 |doi=10.1111/j.1600-065X.1990.tb00565.x]αMβ2 is expressed on the surface of many
leukocyte s involved in theinnate immune system , includingmonocyte s,granulocyte s,macrophage s, andnatural killer cell s. It mediates inflammation by regulating leukocyte adhesion and migration and has been implicated in several immune processes such asphagocytosis , cell-mediated cytotoxicity,chemotaxis and cellular activation. It is involved in thecomplement system due to its capacity to bind inactivatedcomplement component 3b (iC3b). [cite journal |author=Arnaout M, Todd R, Dana N, Melamed J, Schlossman S, Colten H |title=Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol) |journal=J Clin Invest |volume=72 |issue=1 |pages=171–9 |year=1983 |pmid=6874946 |doi=10.1172/JCI110955] The ITGAM (alpha) subunit of integrin αMβ2 is directly involved in causing the adhesion and spreading of cells but cannot mediate cellular migration without the presence of the β2 (CD18) subunit.In genomewide association studies, single nucleotide polymorphisms in ITGAM had the strongest association with
systemic lupus erythematosus , with an odds ratio of 1.65 for the T allele of rs9888739 and lupus. [cite journal |author=Mary K. Crow
title=Collaboration, Genetic Associations, and Lupus Erythematosus
journal=N Engl J Med
volume=358
issue=9
pages=956–961
year=2008
date=February 28, 2008
pmid=18204099
url=http://content.nejm.org/cgi/content/full/358/9/956
doi=10.1056/NEJMe0800096] [cite journal |author=Geoffrey Hom, Robert R. Graham, Barmak Modrek, et al.
title=Association of Systemic Lupus Erythematosus with C8orf13–BLK and ITGAM–ITGAX
journal=N Engl J Med
volume=358
issue=9
pages=900–909
year=2008
date=February 28, 2008
pmid=18204098
url=http://content.nejm.org/cgi/content/full/358/9/900
doi=10.1056/NEJMoa0707865]ee also
*
integrin References
Further reading
PBB_Further_reading
citations =
*cite journal | author=Stewart M, Thiel M, Hogg N |title=Leukocyte integrins. |journal=Curr. Opin. Cell Biol. |volume=7 |issue= 5 |pages= 690–6 |year= 1996 |pmid= 8573344 |doi=
*cite journal | author=Todd RF, Petty HR |title=Beta 2 (CD11/CD18) integrins can serve as signaling partners for other leukocyte receptors. |journal=J. Lab. Clin. Med. |volume=129 |issue= 5 |pages= 492–8 |year= 1997 |pmid= 9142045 |doi=
*cite journal | author=Schymeinsky J, Mócsai A, Walzog B |title=Neutrophil activation via beta2 integrins (CD11/CD18): molecular mechanisms and clinical implications. |journal=Thromb. Haemost. |volume=98 |issue= 2 |pages= 262–73 |year= 2007 |pmid= 17721605 |doi=External links
*
PBB_Controls
update_page = yes
require_manual_inspection = no
update_protein_box = yes
update_summary = no
update_citations = yes
Wikimedia Foundation. 2010.